Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales

20 hours ago

Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.This …